米国の持続気道陽圧（CPAP）装置市場：市場規模・シェア・動向分析 (接続方法別・最終用途別)、セグメント別予測 (2025年～2030年)

米国の持続気道陽圧装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の持続気道陽圧（CPAP）装置市場は2025年から2030年にかけてCAGR 4.44％を記録し、2030年には8億2,085万米ドルに達すると予測されています。

同市場は、睡眠時無呼吸症候群や呼吸器疾患の有病率の増加、CPAP装置技術の進歩、睡眠時無呼吸症候群に対する認識と診断の増加、支援的な償還政策など、いくつかの要因によって牽引されています。

技術進歩は米国のCPAP市場のもう一つの重要な促進要因です。絶え間ない技術革新により、より使いやすく、より静かでコンパクトな機器が開発され、患者の快適性とコンプライアンスが向上しています。遠隔監視や接続機能などの革新的な技術を導入することで、患者は自分の睡眠パターンと治療経過を追跡できるようになり、医療への積極的な関与が促進されます。

医療機関や政府機関による啓蒙キャンペーンの増加により、睡眠時無呼吸症候群の診断や治療を求める人が増えています。さらに、保険会社による好意的な払い戻し政策により、CPAP療法はより幅広い層にとって利用しやすくなっています。未治療の睡眠時無呼吸症候群に伴う合併症の予防というCPAP療法の長期的な利点が認識されたことで、医療提供者も頻繁にCPAP装置を推奨し処方するようになりました。

米国の持続気道陽圧装置市場：分析概要

• 接続方法別では、接続式が2024年に68.83%の最大市場シェアを占め、予測期間中最も速いCAGRで成長すると予測されます。このセグメントの成長は、リアルタイムのモニタリングやテーラーメイド治療のための技術統合の改善など、睡眠時無呼吸症候群管理の進歩が牽引しています。
• 最終用途別では、在宅医療分野が2024年に最大の市場シェアを占め、予測期間には最も速いCAGRで成長すると予測されています。このセグメントの拡大は、閉塞性睡眠時無呼吸症候群（OSA）の有病率の増加とCPAP技術の進歩によってもたらされ、患者にとって手頃で快適かつ便利なソリューションとして在宅医療用CPAP療法の採用が増加しています。
• 米国のCPAP装置市場の有力企業には、ResMed、Koninklijke Philips N.V.、Fisher &Paykel Healthcare Limited、Medical Depot, Inc.
• 2024年11月、フィッシャー＆ペイケルヘルスケアは、米国でF&P Nova Micro鼻ピローマスクを発表しました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場動向と展望
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 市場機会の分析
  • 市場の課題の分析
• 米国のCPAP装置市場：分析ツール、PESTEL分析
  • 政治・法律
  • 経済・社会
  • 技術
  • 環境
• 米国のCPAP装置市場：ポーターのファイブフォース分析
• COVID-19の影響分析

第4章 米国のCPAP装置市場：接続方法別の推定・動向分析

• 米国のCPAP装置市場：変動分析、接続方法別
• 米国のCPAP装置市場：ダッシュボード、接続方法別
• 市場動向と市場シェア分析：接続方法別（2024年・2030年）
• 接続方法別
• 接続式
  • Bluetooth接続CPAP
  • Wi-Fi・セルラー接続CPAP
  • ハイブリッド接続
• 非接続式

第5章 米国のCPAP装置市場：最終用途別の推定・動向分析

• 米国のCPAP装置市場：変動分析、最終用途別
• 米国のCPAP装置市場：ダッシュボード、最終用途別
• 市場動向と市場シェア分析：最終用途別（2024年・2030年）
• 最終用途別
• 在宅医療
• 病院・クリニック
• その他（介護施設等）

第6章 競合情勢

• 企業分類
• 主要企業の参入・退出戦略と競合他社への影響
• 企業の市況分析
• 企業別シェア分析（%、2012～2024年）
• 企業プロファイル/上場企業
  • ResMed
  • Koninklijke Philips NV
  • Fisher &Paykel Healthcare Limited
  • React Health（3B Medical）
  • Lowenstein Medical
  • BMC Medical
  • Wellell（Apex Medical）
  • Armstrong Medical
  • Breas Medical
  • SEFAM
  • Smiths Group PLC
  • Transcend Inc.（Somnetics International, Inc.）
  • Trudell Medical（Vyaire）
  • Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
  • Invacare Corporation
  • その他

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2018 - 2030 (USD Million) (000' Units)
• Table 4 U.S continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million) (000' Units)

List of Figures

• Fig. 1 U.S CPAP Devices Market Segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain based sizing & forecasting
• Fig. 7 QFD modelling for Market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Technology segment outlook
• Fig. 11 Application segment outlook
• Fig. 12 End Use segment outlook
• Fig. 13 Competitive landscape
• Fig. 14 U.S CPAP Devices Market: Market dynamics
• Fig. 15 U.S CPAP Devices Market: Porter's analysis
• Fig. 16 U.S CPAP Devices Market: PESTLE analysis
• Fig. 17 U.S CPAP Devices Market: Connectivity segment dashboard
• Fig. 18 U.S CPAP Devices Market: Connectivity movement share analysis
• Fig. 19 Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 20 Bluetooth-Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 22 Hybrid-Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 23 Non-Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 24 U.S CPAP Devices Market: End Use Segment Dashboard
• Fig. 25 U.S CPAP Market: End Use Movement Share Analysis
• Fig. 26 Home Care Settings Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 27 Hospitals & Clinics Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 28 Others (Long-Term Care Facilities, etc.) Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 29 Company categorization
• Fig. 30 Company Market Share Analysis (2012 - 2024) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
• Fig. 31 Strategic framework

U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends:

The U.S. continuous positive airway pressure devices market is anticipated to reach USD 820.85 million by 2030, registering a CAGR of 4.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.

Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.

Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.

U.S. Continuous Positive Airway Pressure Devices Market Report Highlights:

• On the basis of connectivity, the connected segment held the largest market share of 68.83% in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The growth of this segment is driven by advancements in sleep apnea management, including improved technology integration for real-time monitoring and tailored care, which enhances user adherence and treatment effectiveness.
• On the basis of end use, the home care settings segment held the largest market share in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The expansion of this segment is driven by the increasing prevalence of obstructive sleep apnea (OSA) and advancements in CPAP technology, which are increasing the adoption of homecare CPAP therapy as an affordable, comfortable, and convenient solution for patients.
• Some prominent players in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
• In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro nasal pillow mask in the U.S., marking the company's smallest and lightest CPAP therapy mask so far.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. U.S. CPAP Devices Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Connectivity segment outlook
    • 2.1.2.2. End Use segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
    • 3.3.1.2. Technological advancements
    • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Product recalls & failure
    • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
  • 3.3.3. Market Opportunity Analysis
    • 3.3.3.1. Growing adoption of CPAP devices in home care settings
  • 3.3.4. Market Challenges Analysis
    • 3.3.4.1. Regulatory and reimbursement challenges
• 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
  • 3.4.1. Political & Legal
  • 3.4.2. Economic & Social
  • 3.4.3. Technology
  • 3.4.4. Environment
• 3.5. U.S. CPAP Market Analysis Tools: Porter's
• 3.6. COVID 19 Impact Analysis

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

• 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
• 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
• 4.3. Connectivity Movement & Market Share Analysis, 2024 & 2030
• 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
• 4.5. Connected
  • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.2. Bluetooth-Connected CPAP
    • 4.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.3. Wi-Fi & Cellular Connected CPAP
    • 4.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.4. Hybrid-Connected
    • 4.5.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 4.6. Non-Connected
  • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

• 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
• 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
• 5.3. End Use Movement & Market Share Analysis, 2024 & 2030
• 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
• 5.5. Home Care Settings
  • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 5.6. Hospitals & Clinics
  • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 5.7. Others (Long-Term Care Facilities, etc.)
  • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategies of Market Players for Entry and Exit and its Impact on Market Competitors
• 6.3. Company Market Position Analysis
• 6.4. Company Share Analysis, from 2012 to 2024 (%)
• 6.5. Company Profiles/Listing
  • 6.5.1. ResMed
    • 6.5.1.1. Overview
    • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Koninklijke Philips N.V.
    • 6.5.2.1. Overview
    • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Fisher & Paykel Healthcare Limited
    • 6.5.3.1. Overview
    • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. React Health (3B Medical)
    • 6.5.4.1. Overview
    • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Lowenstein Medical
    • 6.5.5.1. Overview
    • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. BMC Medical
    • 6.5.6.1. Overview
    • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. Wellell (Apex Medical)
    • 6.5.7.1. Overview
    • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Armstrong Medical
    • 6.5.8.1. Overview
    • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Breas Medical
    • 6.5.9.1. Overview
    • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. SEFAM
    • 6.5.10.1. Overview
    • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Smiths Group PLC
    • 6.5.11.1. Overview
    • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Transcend Inc. (Somnetics International, Inc.)
    • 6.5.12.1. Overview
    • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. Trudell Medical (Vyaire)
    • 6.5.13.1. Overview
    • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
    • 6.5.14.1. Overview
    • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.14.3. Product benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. Invacare Corporation
    • 6.5.15.1. Overview
    • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.15.3. Product benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. Others
    • 6.5.16.1. Overview
    • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.16.3. Product benchmarking
    • 6.5.16.4. Strategic initiatives